Multi-omics indicators of long-term survival benefits after immune checkpoint inhibitor therapy

Molecular indicators of long-term survival (LTS) in response to immune-checkpoint inhibitor (ICI) treatment have the potential to provide both mechanistic and therapeutic insights. In this study, we construct predictive models of LTS following ICI therapy based on data from 158 clinical trials invol...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jie, Dong, Yiting, Bai, Hua, Bai, Fan, Yan, Xiaoyan, Duan, Jianchun, Wan, Rui, Xu, Jiachen, Fei, Kailun, Wang, Jie, Wang, Zhijie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626191/
https://www.ncbi.nlm.nih.gov/pubmed/37738982
http://dx.doi.org/10.1016/j.crmeth.2023.100596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626191/
https://www.ncbi.nlm.nih.gov/pubmed/37738982
http://dx.doi.org/10.1016/j.crmeth.2023.100596

Ejemplares similares